Announced Wed, 1 Jul · 18:18 IST
Lupin consolidates Philippines arm MPPI to 99.89% ownership
LUPIN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+3.5%1-day move
₹2396.30
prior close
₹2420.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.8-0.9-0.7-1.0+3.5+3.9+3.9+2.6+4.6+3.8+0.1———
Up moveDown movePending
AI summary
Lupin's Dutch subsidiary Nanomi has completed acquisition of 11,794,497 shares of Multicare Pharmaceuticals Philippines (MPPI) from existing shareholders on July 1, 2026. MPPI has also bought back 61,118 shares from two shareholders, with another 30,559 shares still in progress. Post these transactions, Nanomi's stake in MPPI rose from 56.28% to 99.89%, making MPPI an almost wholly-owned subsidiary of Lupin.
Likely market impact
Gives Lupin full control over its Philippines business, simplifies subsidiary structure, and should have minimal impact on consolidated financials.